Literature DB >> 6209003

Effects of diethyldithiocarbamate and nine other nucleophiles on the intersubunit protein cross-linking and inactivation of purified human alpha 2-macroglobulin by cis-diamminedichloroplatinum(II).

S L Gonias, A C Oakley, P J Walther, S V Pizzo.   

Abstract

The cross-linking and inactivation of the plasma protein alpha 2-macroglobulin by cis-diamminedichloroplatinum(II) (cisplatin; Gonias, S. L., and Pizzo, S. V. J. Biol. Chem., 256: 12478-12484, 1981) was used to study platinum(II)-protein binding in the presence of compounds of therapeutic or biochemical significance. Diethyldithiocarbamate, potassium cyanide (KCN), sodium thiocyanate, L-methionine, N-acetyl-L-cysteine, 2-aminoethanethiol, L-cysteine, L-lysine, L-histidine, and L-arginine demonstrated variable capacity to inhibit reaction of cisplatin with protein and to reverse bidentate platinum(II)-protein binding in the in vitro model system. alpha 2-Macroglobulin lost 90% of its activity and was completely cross-linked, as determined with polyacrylamide gel electrophoresis, after reaction with cisplatin (0.6 to 1.0 mM). When diethyldithiocarbamate (4 to 15 mM) was incubated with alpha 2-macroglobulin and cisplatin, protein inactivation and cross-linking were totally prevented. In experiments with alpha 2-macroglobulin-platinum(II) complex, purified by gel filtration chromatography, 1.0 mM diethyldithiocarbamate completely reactivated the protein and eliminated nearly all of the intersubunit cross-links. Only KCN was comparably effective as an inhibitor of the reaction of cisplatin with alpha 2-macroglobulin; however, KCN was significantly less reactive with preformed platinum(II)-protein bonds than was diethyldithiocarbamate. N-Acetyl-L-cysteine, 2-aminoethanethiol, and L-cysteine were moderately reactive with free cisplatin. This group of compounds also demonstrated a low level of reactivity with the purified alpha 2-macroglobulin-platinum(II) complex. L-Methionine inhibited reaction of cisplatin with the protein, but was ineffective at reversing the reaction in the concentration range studied. The remaining compounds had little or no effect on the reaction of cisplatin with alpha 2-macroglobulin. The ability of diethyldithiocarbamate to displace nucleophilic protein groups from highly stable bonds with platinum(II) may be critical in its function as a rescue agent, limiting cisplatin toxicity towards nontumor cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209003

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Structural analysis of the multienzyme aminoacyl-tRNA synthetase complex: a three-domain model based on reversible chemical crosslinking.

Authors:  M T Norcum; J A Warrington
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

2.  Modification of the tandem reactive centres of human inter-alpha-trypsin inhibitor with butanedione and cis-dichlorodiammineplatinum(II).

Authors:  M W Swaim; S V Pizzo
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

3.  Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site.

Authors:  S V Pizzo; P A Roche; S R Feldman; S L Gonias
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

4.  Physiological pharmacokinetic modeling of cis-dichlorodiammineplatinum(II) (DDP) in several species.

Authors:  F G King; R L Dedrick; F F Farris
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

Review 5.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

6.  Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells.

Authors:  I M Pannacciulli; R A Lerza; G V Bogliolo; M P Mencoboni; A G Saviane
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

7.  Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues.

Authors:  Qing Chang; Olga I Ornatsky; Iram Siddiqui; Rita Straus; Vladimir I Baranov; David W Hedley
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.